Jaguar Health
(NASDAQ) JAGX
Jaguar Health Financials at a Glance
Market Cap
$5.58M
Revenue (TTM)
$11.51M
Net Income (TTM)
$53.58M
EPS (TTM)
$-36.56
P/E Ratio
-0.01
Dividend
$0.00
Beta (Volatility)
1.65 (High)
Dividend
$0.00
Beta (Volatility)
1.65 (High)
Price
$0.41
Volume
739,242.797
Open
$0.42
Price
$0.41
Volume
739,242.797
Open
$0.42
Previous Close
$0.42
Daily Range
$0.40 - $0.44
52-Week Range
$0.31 - $15.48
Dividend
$0.00
Beta (Volatility)
1.65 (High)
Price
$0.41
Volume
739,242.797
Open
$0.42
Previous Close
$0.42
Daily Range
$0.40 - $0.44
52-Week Range
$0.31 - $15.48
JAGX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Jaguar Health
Industry
Pharmaceuticals
Sector
Health CareEmployees
47
CEO
Lisa A. Conte, MBA
Website
www.jaguar.healthHeadquarters
San Francisco, CA 94104, US
JAGX Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
-4%
Net Income Margin
-5%
Return on Equity
-371%
Return on Capital
20%
Return on Assets
-1%
Earnings Yield
-100.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.58M
Shares Outstanding
13.02M
Volume
739.24K
Short Interest
0.00%
Avg. Volume
3.40M
Financials (TTM)
Gross Profit
$7.74M
Operating Income
$45.91M
EBITDA
$45.91M
Operating Cash Flow
$5.80M
Capital Expenditure
$25.00K
Free Cash Flow
$5.77M
Cash & ST Invst.
$968.00K
Total Debt
$43.61M
Jaguar Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.23M
-7.8%
Gross Profit
$1.59M
-46.0%
Gross Margin
49.30%
N/A
Market Cap
$5.58M
N/A
Market Cap/Employee
$113.88K
N/A
Employees
49
N/A
Net Income
$23.20M
-133.9%
EBITDA
$20.50M
-30.1%
Quarterly Fundamentals
Net Cash
$42.64M
-49.5%
Accounts Receivable
$1.70M
+3.1%
Inventory
$8.60M
-16.9%
Long Term Debt
$15.97M
-34.0%
Short Term Debt
$27.63M
+124.0%
Return on Assets
-1.40%
N/A
Return on Invested Capital
19.69%
N/A
Free Cash Flow
$5.51M
+29.6%
Operating Cash Flow
$5.54M
+29.2%